Atlantic International Corp.

NASDAQ:ATLN

Medical - Diagnostics & Research

Healthcare
$0.90 -13.84%

-$0.10 today

Market cap
$73.17M
Beta
0.71
P/E (TTM)
-0.6
EPS (TTM)
-$1.08
52W Low $0.60High $5.25

Volume 18.56M

Average 0.44M

ATLN Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Atlantic International Corp.NASDAQ: ATLN

Gross Margin · Q4 FY2025 · quarter ended Dec 2025

Gross margin narrows to 9.1%

Gross margin was 9.1% in Q4 FY2025, down 1.2 pp from a year earlier. On a trailing-twelve-month basis it was 10.6%, down 0.1 pp year over year. Over 3 fiscal years it narrowed by 1.7 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
9.1%-2.1 pp QoQ
Last fiscal yearDec 2025
10.6%-0.1 pp YoY
LTMDec 2025
10.6%-0.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.2 pp——
1 year-0.1 pp——
3 years-1.7 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
10.6%
Year-over-year change
-0.1pp

Gross Margin vs competitors

How ATLN compares with its peers on the latest reported figures

  • ATLN's LTM Dec 2025 gross margin of 10.6% is the lowest of the 6 companies compared; the peer median is 48.0%.
  • Its year-over-year change of -0.1 pp is the 2nd highest of 5, against a peer median of -20.2 pp.
  • Over three fiscal years its change of -1.7 pp compares with a peer median of -7.4 pp.
ATLN Competitors Peer median
Gross Margin for ATLN and competitors
Company Period LTM level YoY 3-year change
MISTMilestone Pharmaceuticals Inc.LTM Mar 202694.7% —-7.4 pp
PREPrenetics Global LimitedLTM Mar 202658.3% +12.7 pp+25.3 pp
STIMNeuronetics, Inc.LTM Mar 202648.0% -15.6 pp-27.8 pp
AVRAnteris Technologies Global Corp.LTM Mar 202628.3% -24.8 pp-25.9 pp
IMDXInsight Molecular Diagnostics Inc.LTM Mar 202619.5% -33.1 pp+6.6 pp
ATLNAtlantic International Corp.LTM Dec 202510.6% -0.1 pp-1.7 pp
NKTXNkarta, Inc.FY2025— ——
PEPGPepGen Inc.FY2025— ——
Peer median (excluding ATLN) 48.0%-20.2 pp-7.4 pp

Competitors are the stored peer set for ATLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue425.03M441.54M401.37M442.61M435.88M
Cost of Revenue370.62M387.34M354.5M395.43M389.89M
Gross Profit54.41M54.21M46.88M47.18M45.99M
Gross Margin12.8%12.3%11.7%10.7%10.6%
Research & Development00000
Selling, General & Admin42.18M42.27M45.44M64.02M91.29M
Operating Expenses90.14M48.23M50.33M69.01M96.22M
Depreciation & Amortization4.11M5.07M5.04M4.99M6.59M
EBITDA12.18M11.94M1.44M(113.1M)(43.64M)
EBITDA Margin2.9%2.7%0.4%-25.6%-10.0%
Operating Income(35.73M)5.98M(3.45M)(21.83M)(50.23M)
Operating Margin-8.4%1.4%-0.9%-4.9%-11.5%
Interest Income36.46K44.88K000
Interest Expense208.29K90.75K17.54M12M9.16M
Other Income / Expenses(3.73M)(8.39M)(17.73M)(108.27M)(9.16M)
Income Before Tax(39.46M)(2.41M)(21.18M)(130.1M)(59.4M)
Pre-Tax Margin-9.3%-0.5%-5.3%-29.4%-13.6%
Income Tax Expense1.33M808.43K(5.93M)5.38M33.99K
Net Income(40.8M)(3.22M)(15.25M)(135.48M)(59.43M)
Net Margin-9.6%-0.7%-3.8%-30.6%-13.6%
EPS (Basic)(0.17)(0.19)(0.60)(3.68)(1.08)
EPS (Diluted)(0.17)(0.17)(0.60)(3.68)(1.08)
Weighted Avg Shares21.69M21.69M25.42M36.78M54.85M
Weighted Avg Shares (Diluted)21.69M24.14M25.42M36.78M54.85M

Atlantic International Corp.

NASDAQ:ATLN

Intrinsic Alpha fair value

Locked

Current Price

$0.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.